Back to library

BPC-157

healing

Body Protection Compound-157

Mechanism of Action

A pentadecapeptide derived from human gastric juice. Promotes angiogenesis, upregulates growth factor expression (VEGF, EGF), modulates nitric oxide synthesis, and protects the GI tract. Demonstrated tissue-healing properties across muscle, tendon, ligament, bone, and gut in animal models.

Common Doses
250mcg
2x dailysubcutaneous
500mcg
1x dailysubcutaneous
500mcg
2x dailyoral
Common Protocols
Standard Healing4-8 weeks

250mcg subcutaneous 2x daily near injury site

Wolverine Stack6-8 weeks

BPC-157 250mcg + TB-500 2mg 2x/week

Gut Healing4-6 weeks

500mcg oral 2x daily on empty stomach

Safety Notes

No human clinical trials completed. Animal studies show favorable safety profile. Promotes angiogenesis — theoretical concern for existing tumors. Not FDA-approved. Almost all evidence comes from a single Croatian research group.

Legal Status

United States

Category 1 (pending)

Australia

Schedule 4

United Kingdom

Unregulated (RUO)

Ready to track this peptide?

Start Experiment

This information is for educational purposes only. N1X does not recommend, endorse, or facilitate access to any substance. Always consult a qualified healthcare provider before starting any protocol.